Cansino Biologics Inc (688185) — Working Capital to Net Assets Ratio
Cansino Biologics Inc (688185) has a Working Capital to Net Assets ratio of 57.8% as of September 2025. Working capital of CN¥2.85 Billion (current assets of CN¥3.94 Billion minus current liabilities of CN¥1.09 Billion) is measured against net assets of CN¥4.93 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Cansino Biologics Inc balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cansino Biologics Inc Working Capital to Net Assets (2016–2024)
This chart shows how Cansino Biologics Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 57.8%, reflecting working capital of CN¥2.85 Billion against net assets of CN¥4.93 Billion CNY. Check Cansino Biologics Inc (688185) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Cansino Biologics Inc (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cansino Biologics Inc from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 688185 company net worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 51.1% | CN¥2.51 Billion | CN¥4.92 Billion | CN¥4.28 Billion | CN¥1.77 Billion | ▲ +1.6 pp |
| 2023 | 49.5% | CN¥2.62 Billion | CN¥5.29 Billion | CN¥5.18 Billion | CN¥2.57 Billion | ▼ -16.6 pp |
| 2022 | 66.1% | CN¥4.79 Billion | CN¥7.25 Billion | CN¥7.73 Billion | CN¥2.94 Billion | ▼ -9.0 pp |
| 2021 | 75.0% | CN¥6.41 Billion | CN¥8.55 Billion | CN¥9.29 Billion | CN¥2.87 Billion | ▼ -7.5 pp |
| 2020 | 82.5% | CN¥5.01 Billion | CN¥6.07 Billion | CN¥5.42 Billion | CN¥409.47 Million | ▲ +37.0 pp |
| 2019 | 45.6% | CN¥669.95 Million | CN¥1.47 Billion | CN¥794.25 Million | CN¥124.30 Million | ▲ +22.8 pp |
| 2018 | 22.8% | CN¥114.32 Million | CN¥502.32 Million | CN¥221.00 Million | CN¥106.69 Million | ▼ -28.9 pp |
| 2017 | 51.7% | CN¥313.99 Million | CN¥607.33 Million | CN¥426.92 Million | CN¥112.93 Million | ▼ -4.0 pp |
| 2016 | 55.7% | CN¥119.45 Million | CN¥214.47 Million | CN¥146.81 Million | CN¥27.36 Million | — |